Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Search

Type in a keyword to search

on page 1 showing 10 out of 375 results
https://web.expasy.org/cellosaurus/CVCL_A794

Cite this: (NCI-DTP Cat# HL-60, RRID:CVCL_A794)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: NCI-60 cancer cell line panel. Doubling time: 28.6 hours (NCI-DTP). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (c.238C>T) (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (c.182A>T) (PubMed=17088437). Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0062

Cite this: (BCRC Cat# 60425, RRID:CVCL_0062)
Organism: Homo sapiens
Disease: Breast adenocarcinoma
Category: Cancer cell line
Comment: Group: Triple negative breast cancer (TNBC) cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: ICBP43 breast cancer cell line panel. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10583 (CMCC #10583). Doubling time: 1.3 days (PubMed=9671407); 41.9 hours (NCI-DTP); 38 hours (ATCC); ~25-30 hours (DSMZ); ~38 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Heterozygous for BRAF p.Gly464Val (c.1391G>T) (PubMed=17088437). Sequence variation: Heterozygous for KRAS p.Gly13Asp (c.38G>A) (PubMed=17088437). Sequence variation: Homozygous for TP53 p.Arg280Lys (c.839G>A) (PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=28889351). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: Secretome proteome analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: MDA-MD-231; In Cosmic 1071900 and Cosmic 1176602. Misspelling: MDA-321; In GEO GSM459713. Misspelling: MDA-MG-231; In PubMed=6582512. Misspelling: MD-MBA-231; Occasionally. Discontinued: ATCC; CRL-12532. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0062

Cite this: (DSMZ Cat# ACC-732, RRID:CVCL_0062)
Organism: Homo sapiens
Disease: Breast adenocarcinoma
Category: Cancer cell line
Comment: Group: Triple negative breast cancer (TNBC) cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: ICBP43 breast cancer cell line panel. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10583 (CMCC #10583). Doubling time: 1.3 days (PubMed=9671407); 41.9 hours (NCI-DTP); 38 hours (ATCC); ~25-30 hours (DSMZ); ~38 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Heterozygous for BRAF p.Gly464Val (c.1391G>T) (PubMed=17088437). Sequence variation: Heterozygous for KRAS p.Gly13Asp (c.38G>A) (PubMed=17088437). Sequence variation: Homozygous for TP53 p.Arg280Lys (c.839G>A) (PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=28889351). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: Secretome proteome analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: MDA-MD-231; In Cosmic 1071900 and Cosmic 1176602. Misspelling: MDA-321; In GEO GSM459713. Misspelling: MDA-MG-231; In PubMed=6582512. Misspelling: MD-MBA-231; Occasionally. Discontinued: ATCC; CRL-12532. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0105

Cite this: (BCRJ Cat# 0078, RRID:CVCL_0105)
Organism: Homo sapiens
Disease: Prostate carcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 34 hours, at 39th passage (PubMed=631930); 32.3 hours (NCI-DTP); ~29 hours (ATCC); 28-38 hours (CLS); ~30-40 hours (DSMZ); ~29 hours (PBCF). Microsatellite instability: Instable (MSI-high) (PubMed=23671654; Sanger). Sequence variation: Homozygous for CDKN2A p.Asp84Tyr (c.250G>T) (PubMed=17088437). Sequence variation: Homozygous for RB1 p.Lys715Ter (c.2143A>T) (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Lys178fs*86 (c.532_536delAAGCC) (PubMed=17088437). Sequence variation: Heterozygous for TP53 p.Val274Phe (c.820G>T) (PubMed=8104329; PubMed=17088437). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: GPI-anchored proteins analysis by proteomics. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: DU145T; In GEO GSM843494. Derived from metastatic site: Brain.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0553

Cite this: (KCLB Cat# 30133, RRID:CVCL_0553)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: ICBP43 breast cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Part of: NCI-7 clinical proteomics reference material cell line panel. Doubling time: 1.6 days (PubMed=9671407); 45.5 hours (NCI-DTP); ~30-40 hours (DSMZ); ~43 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.His1047Arg (c.3140A>G) (PubMed=17088437; PubMed=28889351). Sequence variation: Homozygous for TP53 p.Leu194Phe (c.580C>T) (PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=21912889; PubMed=28889351). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: T470; In Cosmic 877451 and Cosmic 1152529. Misspelling: T74D; In Cosmic 1027050. Misspelling: T-47D-RU; In Cosmic 1175835. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1452

Cite this: (NCI-DTP Cat# NCI/ADRRES, RRID:CVCL_1452)
Organism: Homo sapiens
Disease: High grade ovarian serous adenocarcinoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=20143388). Part of: NCI-60 cancer cell line panel. Doubling time: 34 hours (NCI-DTP). Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). Sequence variation: Heterozygous for ERBB2 p.Gly776Val (c.2237G>T) (PubMed=17088437). Sequence variation: TP53 p.Tyr126_Lys132del (c.376_396del21) (from parent cell line). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep proteome analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0035

Cite this: (ECACC Cat# 90112714, RRID:CVCL_0035)
Organism: Homo sapiens
Disease: Prostate carcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI-60 cancer cell line panel. Doubling time: 27.1 hours (NCI-DTP); 25 hours (ATCC); ~50 hours (DSMZ); ~25 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Lys139fs*31 (c.413delC) (PubMed=8104329; PubMed=17088437). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Glycoproteome analysis by proteomics. Omics: GPI-anchored proteins analysis by proteomics. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C427. Discontinued: ATCC; CRL-7934. Derived from metastatic site: Bone.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (CLS Cat# 300224/p473_K-562, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (BCRC Cat# 60007, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (DSMZ Cat# ACC-10, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X